Dawn Elizabeth Armstrong
Highly Influential Citations7
Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
BACKGROUND The pattern of adjuvant chemotherapy (AC) use, toxicity profile, and survival benefit in elderly patients with colon cancer (CC) is unclear. We sought to (1) determine whether patients ≥… Continue Reading
Pathologic complete response (pCR) to neoadjuvant chemoradiation for rectal cancer is associated with better long-term outcomes. To assess the rate and predictors of pCR, we performed a retrospective… Continue Reading
Effective management of exploited species demands contemporary knowledge of population structure and mating patterns. Genetic markers can prove useful in providing this knowledge. Despite its… Continue Reading
PURPOSE To determine the variation in medical and surgical procedures experienced by children with cerebral palsy (CP) by Gross Motor Function Classification System (GMFCS) levels and geographical… Continue Reading
BACKGROUND Pathologic complete response (pCR) to neoadjuvant chemoradiation (CRT) for rectal cancer is associated with better long-term outcomes, and is used as an early indicator of response to… Continue Reading
e16210Background: FOLFIRINOX (FFX), gemcitabine/nab-paclitaxel (GN) and gemcitabine (GEM) are 3 available treatments for locally advanced (LAPC) and metastatic (MPC) pancreatic cancer. Without a he...
580 Background: Neoadjuvant chemoradiation (CRT) is the standard of care for patients with locally advanced rectal cancer. Many patients require dose reduction or chemotherapy interruption due to… Continue Reading
476Background: FOLFIRINOX (FFX), gemcitabine plus nab-paclitaxel (GN), and gemcitabine (gem) are 3 publicly funded and available treatment options for locally advanced (LAPC) and metastatic… Continue Reading
416Background: The outcomes of patients (pts) with advanced pancreatic cancer (APC) are poor. With the use of currently available multi-agent regimens, median overall survival (mOS) remains < 12… Continue Reading
581 Background: Although AC is recommended for colon cancer, the pattern of AC use in elderly patients (pts), the toxicity profile, & survival benefit is unclear. We sought to (1)determine whether… Continue Reading